The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in Rabbits
Open accessAbstract
Structure-activity relationships of a lead hydroxamic acid inhibitor of recombinant human stromelysin were systematically defined by taking advantage of a concise synthesis that allowed diverse functionality to be explored at each position in a template. An ex vivo rat model and an in vivo rabbit model of stromelysin-induced cartilage degradation were used to further optimize these analogs for oral activity and duration of action. The culmination of these modifications resulted in CGS 27023A, a potent, orally active stromelysin inhibitor that blocks the erosion of cartilage matrix.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix Metalloproteinases: A Review
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., & Engler, J. A. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040020401 · Cited by 2,970
Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes
Murphy, G., Cockett, M. I., Stephens, P. E., Smith, B. J., & Docherty, A. J. P. (1987) · Biochemical Journal · doi:10.1042/bj2480265 · Cited by 464
Lohmander, L. S., Hoerrner, L. A., & Lark, M. W. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360207 · Cited by 339
Quantification of keratan sulfate in blood as a marker of cartilage catabolism
Thonar, E. J. M. A., Lenz, M. E., Klintworth, G. K., Caterson, B., Pachman, L. M., Glickman, P., Katz, R., Huff, J., & Kuettner, K. E. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780281209 · Cited by 312
Recent advances in matrix metalloproteinase inhibitor research
Beckett, R. P., Davidson, A. H., Drummond, A. H., Huxley, P., & Whittaker, M. (1996) · Drug Discovery Today · doi:10.1016/1359-6446(96)89115-x · Cited by 281
Flannery, C. R., Lark, M. W., & Sandy, J. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48387-1 · Cited by 270
Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage.
Wu, J. J., Lark, M. W., Chun, L. E., & Eyre, D. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67640-4 · Cited by 259
The NMR structure of the inhibited catalytic domain of human stromelysin–1
Gooley, P. R., O’Connell, J. F., Marcy, A. I., Cuca, G. C., Salowe, S. P., Bush, B. L., Hermes, J. D., Esser, C. K., Hagmann, W. K., Springer, J. P., et al. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb0294-111 · Cited by 154
Case, J. P., Sano, H., Lafyatis, R., et al. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114356 · Cited by 91
Lohmander, S. (1988) · Baillière's Clinical Rheumatology · doi:10.1016/s0950-3579(88)80004-9 · Cited by 90
Inhibition of Stromelysin-1 (MMP-3) by P1‘-Biphenylylethyl Carboxyalkyl Dipeptides
Esser, C. K., Bugianesi, R. L., Caldwell, C. G., Chapman, K. T., Durette, P. L., Girotra, N. N., Kopka, I. E., Lanza, T. J., Levorse, D. A., MacCoss, M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960465t · Cited by 67
Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides
Chapman, K. T., Kopka, I. E., Durette, P. L., Esser, C. K., Lanza, T. J., Izquierdo-Martin, M., Niedzwiecki, L. M., Chang, B. C., & Harrison, R. K. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00078a019 · Cited by 64
A quick method for the determination of inhibition constants
Waley, S. G. (1982) · Biochemical Journal · doi:10.1042/bj2050631 · Cited by 61
Gonnella, N. C., Li, Y.-C., Zhang, X., & PARIS, C. G. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(97)00173-9 · Cited by 39
O'BYRNE, E. M., Parker, D. T., Roberts, E. D., GOLDBERG, R. L., MacPherson, L. J., Blancuzzi, V., Wilson, D. E., Singh, H. N., Ludewig, R., & Ganu, V. (1995) · Inflammation Research · doi:10.1007/bf01778290 · Cited by 38
Self-citationSingh, J., Conzentino, P., Cundy, K. C., Gainor, J. A., Gilliam, C. L., Gordon, T. D., Johnson, J. A., Morgan, B. A., Schneider, E. D., Wahl, R. C., et al. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00031-n · Cited by 32
Inhibition of Matrix Metalloproteinases: An examination of the S1′ pocket
Miller, A., Askew, M., Beckett, R. P., Bellamy, C. L., Bone, E. A., Coates, R. E., Davidson, A. H., Drummond, A. H., Huxley, P., Martin, F. M., et al. (1997) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(96)00602-6 · Cited by 27
Jm, M.-M., Dequeker, J., & Gevers, G. (1988) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(88)80005-0 · Cited by 21
GOLDBERG, R. L., Parker, D., MacPherson, L. J., Ganu, V., Melton, R., Hu, S., Blancuzzi, V., Wilson, D. E., Doughty, J., Spirito, S., et al. (1995) · Inflammation Research · doi:10.1007/bf01778289 · Cited by 6
Self-citation
Cited by
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
Whittaker, M., Floyd, C. D., Brown, P., & Gearing, A. J. H. (1999) · Chemical Reviews · doi:10.1021/cr9804543 · Cited by 982
Protease Inhibitors: Current Status and Future Prospects
Leung, D., Abbenante, G., & Fairlie, D. P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990412m · Cited by 883
Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Hu, J., Van den Steen, P. E., Sang, Q.-X. A., & Opdenakker, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2308 · Cited by 795
Matrix metalloproteinases (MMPs): Chemical–biological functions and (Q)SARs
Verma, R. P., & Hansch, C. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.011 · Cited by 783
Metadata
- Authors
- MacPherson, L. J., Bayburt, E. K., Capparelli, M. P., Carroll, B. J., Goldstein, R., Justice, M. R., Zhu, L., Hu, S.-I., Melton, R. A., Fryer, L., Goldberg, R. L., Doughty, J. R., Spirito, S., Blancuzzi, V., Wilson, D., O'Byrne, E. M., Ganu, V., & Parker, D. T.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1997-08-01
- Volume
- 40
- Issue
- 16
- Pages
- 2525-2532
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2115211598
- Cited by
- 326
- References
- 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.